Article
Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.
Pharmacogenomics - 1 Jul 2007
Zanger Ulrich M, Klein Kathrin, Saussele Tanja, Blievernicht Julia, Hofmann Marco H, Schwab Matthias
Abstract excerpt
Polymorphisms in drug-metabolizing enzymes and drug transporters contribute to wide and inheritable variability in drug pharmacokinetics, response and toxicity. One of the less well-studied human cytochrome P450s is (CYP)2B6, a homologue of the rodent phenobarbital-inducible CYP2B enzymes. Clinically used drug substrates include cytostatics (cyclophosphamide), HIV drugs (efavirenz and nevirapine), antidepressants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
